Adar1 Capital Management, LLC Portfolio Holdings

Adar1 Capital Management, LLC

  • $539 Billion
  • Q1 2025

Adar1 Capital Management, LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $539 Billion distributed in 202 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Protagonist Therapeutics, Inc with a value of $45.4B, Ea Series Trust with a value of $37.6B, Roivant Sciences Ltd. with a value of $35.1B, Zai Lab LTD with a value of $34B, and Immunovant, Inc. with a value of $16.6B.

Examining the 13F form we can see an increase of $38.3B in the current position value, from $500B to 539B.

Adar1 Capital Management, LLC is based out at Austin, TX

Below you can find more details about Adar1 Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $539 Billion
Healthcare: $348 Billion
ETFs: $21.5 Billion
Consumer Cyclical: $293 Million
Utilities: $103 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$138M
$468 Million 0.09% of portfolio
380,330
Q1 2025 Added 3.26%
$13.8B
$463 Million 0.09% of portfolio
6,074
Q1 2025 Reduced 72.36%
Agriculture & Nat Sol Acq CO
-
$502 Million 0.09% of portfolio
-
Q1 2025 Reduced 41.44%
$2.16B
$483 Million 0.09% of portfolio
12,800
Q1 2025 New
Instil Bio Inc
-
$422 Million 0.08% of portfolio
-
Q1 2025 Reduced 23.27%
Cidara Therapeutics Inc
-
$451 Million 0.08% of portfolio
-
Q1 2025 Reduced 16.04%
Nabors Energy Transition Cor
-
$437 Million 0.08% of portfolio
-
Q4 2024 Reduced 33.39%
$26.9B
$455 Million 0.08% of portfolio
5,000
Q1 2025 New
$392M
$412 Million 0.08% of portfolio
35,743
Q1 2025 Reduced 0.28%
$518M
$423 Million 0.08% of portfolio
266,176
Q1 2025 Reduced 21.17%
$797M
$440 Million 0.08% of portfolio
20,000
Q1 2025 New
Tenax Therapeutics Inc
-
$450 Million 0.08% of portfolio
-
Q1 2025 Added 98.14%
$31.1B
$355 Million 0.07% of portfolio
600
Q1 2025 New
$2.19B
$372 Million 0.07% of portfolio
17,000
Q1 2025 Added 13.33%
Neurogene Inc
-
$327 Million 0.06% of portfolio
-
Q1 2025 New
$219M
$347 Million 0.06% of portfolio
100,000
Q1 2025 New
-
$303 Million 0.06% of portfolio
-
Q1 2025 Reduced 54.66%
$423M
$315 Million 0.06% of portfolio
30,099
Q1 2025 New
Jvspac Acquisition Corp
-
$322 Million 0.06% of portfolio
-
Q3 2024 New
$183B
$347 Million 0.06% of portfolio
700
Q1 2025 New
$1.1B
$326 Million 0.06% of portfolio
8,000
Q1 2025 New
$115M
$324 Million 0.06% of portfolio
281,600
Q1 2025 Added 126.13%
$10.8B
$346 Million 0.06% of portfolio
4,900
Q1 2025 New
Spyre Therapeutics Inc
-
$243 Million 0.05% of portfolio
-
Q1 2025 New
$122M
$255 Million 0.05% of portfolio
75,545
Q1 2025 Reduced 40.42%
$344M
$268 Million 0.05% of portfolio
42,800
Q1 2025 Reduced 22.74%
$1.09B
$265 Million 0.05% of portfolio
14,600
Q1 2025 New
$117M
$250 Million 0.05% of portfolio
227,228
Q1 2025 Reduced 23.13%
Therapeuticsmd Inc
-
$250 Million 0.05% of portfolio
-
Q2 2024 Reduced 0.73%
$583M
$252 Million 0.05% of portfolio
21,200
Q1 2025 Added 92.73%
$3.92B
$293 Million 0.05% of portfolio
12,000
Q1 2025 New
$2.46B
$274 Million 0.05% of portfolio
10,000
Q4 2024 Reduced 15.65%
Iron Horse Acquisitions Corp
-
$262 Million 0.05% of portfolio
-
Q3 2024 New
$70.5M
$190 Million 0.04% of portfolio
142,958
Q3 2024 Added 53.79%
$1.81B
$212 Million 0.04% of portfolio
5,424
Q1 2025 Reduced 68.87%
$9.61B
$216 Million 0.04% of portfolio
5,000
Q4 2024 Reduced 67.11%
$10.2M
$215 Million 0.04% of portfolio
351,094
Q4 2024 Reduced 6.08%
Colombier Acquisition Corp I
-
$197 Million 0.04% of portfolio
-
Q1 2025 New
$9.76B
$219 Million 0.04% of portfolio
1,402
Q1 2025 Reduced 98.04%
$1.97B
$189 Million 0.04% of portfolio
13,873
Q1 2025 Reduced 69.05%
$509M
$222 Million 0.04% of portfolio
28,023
Q1 2025 Reduced 47.15%
Polypid LTD
-
$217 Million 0.04% of portfolio
-
Q4 2024 Reduced 14.72%
$461M
$200 Million 0.04% of portfolio
30,085
Q1 2025 New
$49M
$161 Million 0.03% of portfolio
146,183
Q1 2025 Added 55.03%
$779M
$139 Million 0.03% of portfolio
16,221
Q4 2024 New
$2.49B
$149 Million 0.03% of portfolio
10,000
Q1 2025 Reduced 75.12%
Biomx Inc
-
$166 Million 0.03% of portfolio
-
Q1 2025 New
$601M
$187 Million 0.03% of portfolio
23,100
Q1 2025 Added 6.45%
$425M
$165 Million 0.03% of portfolio
25,000
Q1 2025 New

Summary

  • Portfolio
  • No. of Stocks 202
  • Current Value $539 Billion
  • Prior Value $500 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 47 stocks
  • Additional Purchases 68 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 40 stocks
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email